Last checked at 
| Tuesday 17 September | |
| JTC | Half Year Results |
| Staffline | Half Year Results |
| Personal Group | Half Year Results |
| Smart Metering Systems | Half Year Results |
| Uniphar | Half Year Results |
| Aquis Exchange | Half Year Results |
| Central Asia Metals | Half Year Results |
| French Connection Group | Half Year Results |
| Ocado Group | Q3 Results |
| Wednesday 18 September | |
| Kingfisher | Half Year Results |
| Accesso Technology | Half Year Results |
| Warpoint London | Half Year Results |
| Pendragon | Half Year Results |
| ClearStar | Half Year Results |
| Maxcyte | Half Year Results |
| Keywords Studios | Half Year Results |
| Bonhill Group | Half Year Results |
| Lloyd's of London | Half Year Results |
| Surgical Innovations | Half Year Results |
| Porvair | Trading Statement |
| Pan African Resources | Full Year Results |
| Thursday 19 September | |
| Clinigen Group | Full Year Results |
| Bluefields | Full Year Results |
| Cambridge Cognition | Half Year Results |
| Xeros Technology | Half Year Results |
| hVIVO | Half Year Results |
| City Pub Group | Half Year Results |
| Next | Half Year Results |
| Saga | Half Year Results |
| Lamprell | Half Year Results |
| Safestyle UK | Half Year Results |
| Kier Group | Full Year Results |
| IG Group | Q1 Results |
| Sound Energy | Half Year Results |
| Wilmington | Full Year Results |
| Friday 20 September | |
| Applegreen | Half Year Results |
| Smiths Group | Full Year Results |
| Hurricane Energy | Half Year Results |
| Investec | Trading Statement |
| Monday 23 September | |
| Brady | Half Year Results |
| Keystone Law | Half Year Results |
| PureCircle | Full Year Results |
| Faron Pharmaceuticals | Half Year Results |
| Billington Holdings | Half Year Results |
| Seeing Machines | Full Year Results |
| ASA International | Half Year Results |
| Oilex | Half Year Results |
| Microsaic Systems | Half Year Results |
| Instem | Half Year Results |
9 Mar 2020 10:26
Faron gets FDA tick from proposed design of next 'Traumakine' study
(Sharecast News) - Faron Pharmaceuticals announced on Monday that the US Food and Drug Administration (FDA) has accepted its proposed protocol design for the next 'Traumakine' study in acute respiratory distress syndrome (ARDS) patients, following its protocol submission in February.
Read more